---
figid: PMC3891116__JZUSB15-0016-fig02
figlink: /pmc/articles/PMC3891116/figure/F2/
number: F2
caption: Essential cell signaling pathways for prostate cancer (PCa) development and
  crosstalks between themThe interaction of circulating androgens (T/DHT) with AR
  is critical for PCa growth. Also, estrogens (E) and their corresponding receptors
  (ER) have a prominent role in prostate carcinogenesis, either by genomic or non-genomic
  actions. In advanced PCa, when the amount of available androgens is limited, other
  cytokines and growth factors promote synergic activities of AR. These molecules
  include TGF-β/BMPs, IL-6, EGF, IGF-1, VEGF, and FGF. Thus, androgen-responsive genes
  continue to be produced, although target genes differ between androgen-dependent
  and androgen-independent cells. In addition to their effects on the androgen pathway,
  these cell signals retain the ability to promote PCa overall survival, growth, and
  dissemination through alternative molecular targets. Grey arrows represent the androgen
  signaling in androgen-dependent PCa. Black arrows represent the prominent activated
  pathways in androgen-independent PCa. Dashed black arrows denote the crosslinks
  between cell signaling pathways. Black triangles symbolize up/down-regulation of
  molecules in PCa. Akt, protein kinase B; AR, androgen receptor; ARA55, androgen
  receptor associated protein 55; ARE, androgen response elements; BAG1L, Bcl-2-associated
  athanogene 1 long isoform; BMPs, bone morphogenetic proteins; BMPR, bone morphogenetic
  protein receptor; DDT, D-dopachrome tautomerase; DHT, dihydrotestosterone; D52,
  tumor protein D52; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor;
  FGF, fibroblast growth factor; FGFR, fibroblast growth factor receptor; FOXO1, forkhead
  box protein O1; GSTT2, glutathione S-transferase θ 2; HIF1A, hypoxia-inducible factor
  1-α; HSP, heat shock proteins; IGF-1, insulin-like growth factor 1; IGFBP, IGF binding
  proteins; IGFR, insulin-like growth factor receptor; IL-6, interleukin 6; IL6R,
  interleukin 6 receptor; JAK, Janus kinase; KLK2, kallikrein-related peptidase 2;
  MAPK, mitogen-activated protein kinase; MEK, upstream kinases of mitogen-activated
  protein kinases; OAT, ornithine aminotransferase; PKC-δ, protein kinase C δ; P13K,
  phosphatidylinositol 3 kinase; PPPs, phosphoprotein phosphatases; PSA, prostate-specific
  antigen; PYCR1, pyrroline-5-carboxylate reductase 1; STAT3, signal transducer and
  activator of transcription 3; T, testosterone; TGF-β, transforming growth factor-β;
  TβR, transforming growth factor-β receptors; TMPRSS2, transmembrane protease serine
  2; TRPV3, transient receptor potential cation channel subfamily V member 3; VEGF,
  vascular endothelial growth factor; VEGFR, vascular endothelial growth factor receptor
pmcid: PMC3891116
papertitle: 'Prostate cancer: the need for biomarkers and new therapeutic targets
  .'
reftext: Juliana Felgueiras, et al. J Zhejiang Univ Sci B. 2014 Jan;15(1):16-42.
pmc_ranked_result_index: '193904'
pathway_score: 0.8256052
filename: JZUSB15-0016-fig02.jpg
figtitle: Essential cell signaling pathways for prostate cancer (PCa) development
  and crosstalks between themThe interaction of circulating androgens (T/DHT) with
  AR is critical for PCa growth
year: '2014'
organisms: Homo sapiens
ndex: e37a84fb-df26-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3891116__JZUSB15-0016-fig02.html
  '@type': Dataset
  description: Essential cell signaling pathways for prostate cancer (PCa) development
    and crosstalks between themThe interaction of circulating androgens (T/DHT) with
    AR is critical for PCa growth. Also, estrogens (E) and their corresponding receptors
    (ER) have a prominent role in prostate carcinogenesis, either by genomic or non-genomic
    actions. In advanced PCa, when the amount of available androgens is limited, other
    cytokines and growth factors promote synergic activities of AR. These molecules
    include TGF-β/BMPs, IL-6, EGF, IGF-1, VEGF, and FGF. Thus, androgen-responsive
    genes continue to be produced, although target genes differ between androgen-dependent
    and androgen-independent cells. In addition to their effects on the androgen pathway,
    these cell signals retain the ability to promote PCa overall survival, growth,
    and dissemination through alternative molecular targets. Grey arrows represent
    the androgen signaling in androgen-dependent PCa. Black arrows represent the prominent
    activated pathways in androgen-independent PCa. Dashed black arrows denote the
    crosslinks between cell signaling pathways. Black triangles symbolize up/down-regulation
    of molecules in PCa. Akt, protein kinase B; AR, androgen receptor; ARA55, androgen
    receptor associated protein 55; ARE, androgen response elements; BAG1L, Bcl-2-associated
    athanogene 1 long isoform; BMPs, bone morphogenetic proteins; BMPR, bone morphogenetic
    protein receptor; DDT, D-dopachrome tautomerase; DHT, dihydrotestosterone; D52,
    tumor protein D52; EGF, epidermal growth factor; EGFR, epidermal growth factor
    receptor; FGF, fibroblast growth factor; FGFR, fibroblast growth factor receptor;
    FOXO1, forkhead box protein O1; GSTT2, glutathione S-transferase θ 2; HIF1A, hypoxia-inducible
    factor 1-α; HSP, heat shock proteins; IGF-1, insulin-like growth factor 1; IGFBP,
    IGF binding proteins; IGFR, insulin-like growth factor receptor; IL-6, interleukin
    6; IL6R, interleukin 6 receptor; JAK, Janus kinase; KLK2, kallikrein-related peptidase
    2; MAPK, mitogen-activated protein kinase; MEK, upstream kinases of mitogen-activated
    protein kinases; OAT, ornithine aminotransferase; PKC-δ, protein kinase C δ; P13K,
    phosphatidylinositol 3 kinase; PPPs, phosphoprotein phosphatases; PSA, prostate-specific
    antigen; PYCR1, pyrroline-5-carboxylate reductase 1; STAT3, signal transducer
    and activator of transcription 3; T, testosterone; TGF-β, transforming growth
    factor-β; TβR, transforming growth factor-β receptors; TMPRSS2, transmembrane
    protease serine 2; TRPV3, transient receptor potential cation channel subfamily
    V member 3; VEGF, vascular endothelial growth factor; VEGFR, vascular endothelial
    growth factor receptor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF12
  - FGF2
  - FGF13
  - FGF1
  - JAK3
  - DDT
  - AKT2
  - FGF5
  - AKT1
  - TGFB1I1
  - IGFBP5
  - TGFB1
  - EGF
  - EGFR
  - FGF3
  - FGF4
  - JAK1
  - TRPV3
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - AR
  - IGFBP4
  - FGF11
  - IGFBP6
  - IGF1R
  - IL6R
  - JAK2
  - TPD52
  - FGF23
  - VEGFA
  - TYK2
  - IGFBP1
  - AKT3
  - IGFBP3
  - FGF10
  - FGFR2
  - MAPK14
  - MAPK1
  - IL6
  - KLK2
  - GSTT2
  - HIF1A
  - SMAD2
  - IGF1
  - MAPK12
  - MAPK10
  - MAPK13
  - FGFR3
  - STAT3
  - TGFBR2
  - BRAF
  - TGFB2
  - TGFB3
  - MAPK8
  - FGF14
  - FGF20
  - FGF18
  - IGFBP7
  - SMAD6
  - IGFBP2
  - SMAD9
  - VEGFC
  - PYCR1
  - NRAS
  - FGFRL1
  - MAPK3
  - FOXO1
  - VEGFD
  - KRAS
  - SMAD4
  - SMAD3
  - OAT
  - PGF
  - VEGFB
  - PTEN
  - RAF1
  - HRAS
  - MAPK11
  - FGFR1
  - FGF21
  - SMAD5
  - FGF16
  - MAPK9
  - SMAD7
  - FGFR4
  - FGF17
  - FGF19
  - ARAF
  - MAP2K1
  - FGF22
  - MAP2K2
  - SMAD1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: DDT,PKC-0,GSTT2,TRPV3,
  symbol: DDT
  source: hgnc_symbol
  hgnc_symbol: DDT
  entrez: '1652'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ARA55
  symbol: ARA55
  source: hgnc_alias_symbol
  hgnc_symbol: TGFB1I1
  entrez: '7041'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP5
  entrez: '3488'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: TRPV3,
  symbol: TRPV3
  source: hgnc_symbol
  hgnc_symbol: TRPV3
  entrez: '162514'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP4
  entrez: '3487'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP6
  entrez: '3489'
- word: IGFR
  symbol: IGFR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: IL6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: TMPRSS2-ETS,KLK2,D52
  symbol: D52
  source: hgnc_alias_symbol
  hgnc_symbol: TPD52
  entrez: '7163'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP1
  entrez: '3484'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP3
  entrez: '3486'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: TMPRSS2-ETS,KLK2,D52
  symbol: KLK2
  source: hgnc_symbol
  hgnc_symbol: KLK2
  entrez: '3817'
- word: GSTT2,
  symbol: GSTT2
  source: hgnc_symbol
  hgnc_symbol: GSTT2
  entrez: '2953'
- word: HIF1A
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: Smads
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: TBR-II
  symbol: TBR-ii
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP7
  entrez: '3490'
- word: Smads
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP2
  entrez: '3485'
- word: Smads
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: PYCR1,
  symbol: PYCR1
  source: hgnc_symbol
  hgnc_symbol: PYCR1
  entrez: '5831'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FOXO1
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Smads
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: Smads
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: OAT
  symbol: OAT
  source: hgnc_symbol
  hgnc_symbol: OAT
  entrez: '4942'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: Smads
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Smads
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: FGF+
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Smads
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3891116__F2
redirect_from: /figures/PMC3891116__F2
figtype: Figure
---
